Abstract
Activation of the hypothalamic-pituitary-adrenal (HPA) axis of fetal sheep during late gestation is associated with increases in plasma concentrations of adrenocorticotropic hormone (ACTH) and cortisol, and ultimately results in parturition. However, the mechanisms contributing to the concurrent increases in ACTH and cortisol are unclear. Plasma estradiol-17β (E2) concentrations increase progressively in the prepartum ovine fetus, and we hypothesized that E2 may influence HPA activity by affecting either basal and/or hypoxemia-stimulated ACTH release. We examined potential mechanisms, including altered expression of pro-opiomelanocortin (POMC) in fetal pituitary corticotrophs, and changes in corticosteroid binding globulin (CBG) and/or the enzymes 11β hydroxy steroid dehydrogenase (11β HSD)-1 or 11β HSD-2 in liver and placenta, that could alter negative feedback control. We infused fetal sheep at 127 d of gestation with either E2 (100 μg/24 h) or saline for 100 h. Fetal arterial blood samples were collected at 8 h intervals during the infusion of E2 or saline (n=4), for measurement of basal plasma ACTH and cortisol concentrations, as well as plasma corticosteroid binding capacity (CBC). Placenta and fetal liver samples were collected at 100 h for measurement of placental 11 β HSD-1 and 11β HSD-2 mRNA and hepatic CBG and 11β HSD-1 mRNA, by Northern blotting. Fetal pituitary samples were collected for measurement of POMC mRNA byin situ hybridization. In a separate experiment, fetuses were exposed to 2 h of hypoxemia at 75 h of E2 or saline infusion (n=4), and fetal arterial blood samples were collected during the period of hypoxemia for measurement of plasma ACTH and cortisol concentrations. E2 infusion had no effect on basal plasma concentrations of ACTH or total cortisol, or on the stimulated levels of ACTH or total cortisol achieved in response to hypoxemia. Basal fetal pituitary POMC mRNA also did not change significantly with E2 infusion. No significant increases were observed in plasma CBC during E2 administration. However, hepatic CBG and 11β HSD-1 mRNA were significantly elevated in the livers of E2-treated fetuses. Placental 11β HSD-1 mRNA; but not 11β HSD-2 mRNA was increased by E2 treatment. These data do not support a direct effect of exogenous E2 at the level of basal or hypoxemia-stimulated ACTH output, but suggest that elevated E2 concentrations may alter the expression of genes encoding proteins implicated in tonic regulation of fetal HPA function.
Similar content being viewed by others
References
Brooks, A. N., Currie, I. S., Gibson, F., and Thomas, G. B. (1992).J. Reprod. Fert.,Suppl. 45, 69–84.
Challis, J. R. G. and Brooks, A. N. (1989).Endocrine Reviews 10, 182–204.
Handa, R. J., Burgess, L. H., Kerr, J. E., and O'Keefe, J. A. (1994).Horm. and Behav. 28, 464–476.
Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F., and de Kloet, E. R. (1995).J. Endocr. 144, 311–321.
Kitay, J. I. (1961).Endocrinology 68, 818–824.
Gemzell, C. A. (1952).Acta Endocr. (Copenh.) 11, 221–228.
Viau, V. and Meaney, M. J. (1991).Endocrinology 129, 2503–2511.
Challis, J. R. G. and Patrick, J. E. (1981).Can. J. Physiol. Pharmacol. 59, 970–978.
Robertson, H. A. and Smeaton, T. C. (1973).J. Reprod. Fert. 35, 461–468.
Saoud, C., Kelleman, A., and Wood, C. E. (1994). Society of Gynecological Investigation Meeting, p. 405, Abstract 397.
Yang, K. (1995).Endocr. Res. 21, 367–377.
Challis, J. R. G., Harrison, F. A., and Heap, R. B. (1973).J. Endocr. 57, 97–110.
Wood, C. E. and Saoud, C. J. (1996). 10th International Congress of Endocrinology June 12–15, p. 862, Abstract P3-429.
Burgess, L. H., and Handa, R. J. (1992).Endocrinology 131, 1261–1269.
Grino, M., Hery, M., Paulmyer Lacroix, O., and Anglade, G. (1995). The Endocrine Society 77th Annual Meeting, Abstract P1-574.
Treiser, S. L. and Wardlaw, S. L. (1992).Neuroendocrinology 55, 167–173.
Pelletier, G. (1993).Ann. NY Acad of Sci. 680, 246–259.
Broad, K. D., Kendrick, K. M., Sirinathsinghi, D. J. S., and Keverne, E. B. (1993).J. Neuroendocrinology 5, 711–719.
Challis, J. R. G., Berdusco, E. T. M., Jeffray, T. M., Yang, K., and Hammond, G. L. (1995).J. Steroid Biochem. & Mol. Bio. 53, 523–527.
Ballard, P. L. (1979). In:Glucocorticoid Hormone Action. Monographs in Endocrinology. Baxter, J. D. and Rousseau, G. G. (eds.). Springer-Verlag: Berlin.
Brien, T. G. (1981).Clin. Endocr. 14, 193–212.
Coolens, J-L., Van Baelen, H., and Heyns, W. (1987).J. Steroid Biochem. 26, 197–202.
Lindholm, J. and Schultz Moller, N. (1973).Scand. J. Clin. Lab. Invest. 31, 119–122.
Moore, D. E., Kawagoe, S., Davajan, V., Mishell, D. R., and Nakamura, R. M. (1978).Am. J. Obstet. Gynecol. 130, 475–481.
Ballard, P. L., Kitterman, J. A., Bland, R. D., Clyman, R. I., Gluckman, P. D., Platzker, A. C., Kaplan, S. L., and Grumbach, M. M. (1982).Endocrinology 110, 359–366.
Challis, J. R. G., Nancekievill, E. A., and Lye, S. J. (1985).Endocrinology 116, 1139–1144.
Hammond, G. L. (1990).Endocr. Rev. 11, 65–79.
Berdusco, E. T. M., Yang, K., Hammond, G. L., and Challis, J. R. G. (1995).J. Endocr. 146, 121–130.
Yang, K., Langlois, D. A., Campbell, L. E., Challis, J. R. G., Krkosek, M., and Yu, M. Placenta, in press.
Berdusco, E. T. M., Milne, W. K., and Challis, J. R. G. (1994).J. Endocr. 140, 425–430.
Pepe, G. J., Waddell, B. J., Stahl, S. J., and Albrecht, E. D. (1988).Endocrinology 122, 78–83.
Baggia, S., Albrecht, E. D., and Pepe, G. J. (1990).Endocrinology 126, 2742–2748.
Pepe, G. J., Davies, W. A., and Albrecht, E. D. (1994).Endocrinology 135, 2581–2587.
Pepe, G. J., Waddell, B. J., and Albrecht, E. D. (1990).Endocrinology 127, 3117–3123.
Akagi, K., and Challis, J. R. G. (1990).Can. J. Physiol. Pharmacol. 68, 549–555.
Challis, J. R. G., Richardson, B. S., Rurak, D., Wlodek, M. E., and Patrick, J. E. (1986).Am. J. Obstet. Gynecol. 155, 1332–1336.
Norman, L. J., Lye, S. J., Wlodek, M. E., and Challis, J. R. G. (1985).Can. J. Physiol. Pharmacol. 63, 1398–1403.
Matthews, S. G., Han, X., Lu, F., and Challis, J. R. G. (1994).J Mol. Endocrinology 13, 175–185.
Yang, K., Matthews, S. G., and Challis, J. R. G. (1995).J. Mol. Endocrinology 14, 109–116.
Gossard, F. J., Chang, A. C. Y., and Cohen, S. N. (1986).Biochim. Biophys. Acta 866, 68–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, S., Matthews, S.G., Jeffray, T.M. et al. The effects of estradiol-17° infusion into fetal sheep in late gestation. Endocr 6, 271–278 (1997). https://doi.org/10.1007/BF02820503
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02820503